Thermo Fisher Scientific Inc.
XETRA: TN8.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper
- Employees
- 125,000
- Headquarters
- Waltham, United States
- IPO year
- 2020
- Market cap
- €146.0B
- Website
- https://www.thermofisher.com
Loading TN8…
Loading profile data…Frequently asked questions about TN8
What does Thermo Fisher Scientific Inc. (TN8.DE) do?
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and pro...
Where does TN8.DE trade?
Thermo Fisher Scientific Inc. (TN8.DE) trades on the Deutsche Börse.
What sector is TN8.DE in?
Thermo Fisher Scientific Inc. (TN8.DE) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Thermo Fisher Scientific Inc.?
Marc N. Casper is the chief executive officer of Thermo Fisher Scientific Inc. (TN8.DE).
Where is Thermo Fisher Scientific Inc. headquartered?
Thermo Fisher Scientific Inc. is headquartered in United States.
Does TN8.DE pay a dividend?
Yes — Thermo Fisher Scientific Inc. (TN8.DE) paid a trailing twelve-month dividend of EUR 1.49 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TN8.DE go public?
Thermo Fisher Scientific Inc. (TN8.DE) completed its initial public offering in 2020.